Discussion on how to optimize active surveillance for low-risk papillary thyroid microcarcinoma in China.
10.3760/cma.j.cn112139-20221014-00442
- Author:
Shuai XUE
1
;
Pei Song WANG
1
;
Qi Yu LU
1
;
Guang CHEN
1
Author Information
1. Thyroid Surgery Department, General Surgery Center, First Hospital of Jilin University, Changchun 130000, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Thyroidectomy/methods*;
Prospective Studies;
Watchful Waiting/methods*;
Thyroid Neoplasms/pathology*;
Disease Progression;
Thyroid Cancer, Papillary/surgery*
- From:
Chinese Journal of Surgery
2023;61(6):462-466
- CountryChina
- Language:Chinese
-
Abstract:
Active surveillance, as a first-line treatment strategy for low-risk papillary thyroid microcarcinoma, has been recommended by guidelines worldwide. However, active surveillance has not been widely accepted by doctors and patients in China. In view of the huge challenges faced by active surveillance, doctors should improve their understanding of the "low risk" of papillary thyroid micropapillary cancer, identify some intermediate or high-risk cases, be familiar with the criteria and methods of diagnosis for disease progression, and timely turn patients with disease progression into more active treatment strategies. By analyzing the long-term cost-effectiveness of active surveillance, it is clear that medical expense is only one cost form of medical activities, and the health cost (thyroid removal and surgical complications) paid by patients due to"over-diagnosis and over-treatment" is the most important. Moreover, the weakening of the patients' social function caused by surgical procedures is a more hidden and far-reaching cost. The formulation of health economic policies (including medical insurance) should promote the adjustment of diagnosis and treatment behavior to the direction which is conducive to the long-term life and treatment of patients, improving the overall health level of society and reducing the overall cost. At the same time, doctors should stimulate the subjective initiative of patients, help them fully understand the impact of various treatment methods on their psychological and physical status, support patients psychologically, and strengthen their confidence in implementing active surveillance. By strengthening multi-disciplinary treatment team and system support, doctors can achieve risk stratification of papillary thyroid microcarcinoma, accurate judgment of disease progress, timely counseling for psychological problems, and long-term adherence to active surveillance. Improving the treatment level of advanced thyroid cancer is the key point of improve the prognosis. It is important to promote the development of active surveillance for low-risk papillary thyroid microcarcinoma. In the future, it is necessary to carry out multi-center prospective research and accumulate research evidence for promoting the standardization process of active surveillance. Standardized active surveillance will certainly benefit specific papillary thyroid microcarcinoma patients.
